8-KOther Events

ABBOTT LABORATORIES 8-K Report (Jul 10, 2003)

Filed July 10, 2003For Securities:ABT

Summary

Abbott Laboratories (ABT) filed an 8-K on July 10, 2003, to announce its second quarter 2003 financial results. The filing primarily includes a press release detailing the company's performance during the quarter. Investors should note that Abbott utilized non-GAAP financial measures in its reporting, which exclude certain one-time charges and the impact of foreign exchange. The company asserts that these adjusted measures offer a clearer view of ongoing business performance and are used internally for management monitoring.

Key Highlights

  • 1Abbott Laboratories announced its second quarter 2003 results on July 10, 2003.
  • 2The filing is an 8-K report primarily furnishing a press release with financial results.
  • 3Non-GAAP financial measures were used, including net earnings and diluted EPS excluding one-time charges.
  • 4Sales performance excluding the impact of foreign exchange was also presented.
  • 5Abbott's management believes these non-GAAP measures provide useful insights into ongoing business performance.
  • 6Investors are cautioned to consider these non-GAAP measures alongside GAAP-based financial information.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce Abbott Laboratories' financial results for the second quarter of 2003. It also serves to furnish the press release containing these results as an exhibit.

Abbott uses both GAAP (Generally Accepted Accounting Principles) and non-GAAP financial measures. The press release details results both including and excluding 'one-time charges' and the impact of foreign exchange, with the latter being the non-GAAP measures.

Abbott's management states that non-GAAP measures, which exclude items like one-time charges and foreign exchange impacts, are used to provide investors with a clearer perspective on the company's ongoing business performance. These adjusted figures are also used internally by management for performance monitoring.

Investors should consider the non-GAAP financial measures in conjunction with, and not as a substitute for, the financial measures prepared in accordance with GAAP. This ensures a comprehensive understanding of the company's financial health.